Concepedia

Publication | Open Access

An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing’s Syndrome and Autonomous Cortisol Secretion

30

Citations

49

References

2021

Year

Abstract

S-707106 is an effective insulin sensitizer and antisarcopenic and antiobesity medication for these patients.

References

YearCitations

Page 1